Delivery Order SPE2DB20D2014-SPE2DB25FC14A
Award Date 6/6/25
Potential Completion Date 6/9/25
Potential Value $5.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $8,192.61 to supply FORTEO (teriparatide) 560 micrograms per 2.24 milliliter pen injections. This competitively awarded, firm fixed price delivery order was issued on August 5, 2025, with an ultimate completion date of August 6, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. FORTEO is a prescription medication used to treat osteoporosis,...
- The Defense Logistics Agency awarded a $6,492.02 delivery order to AmerisourceBergen Drug Corp for FORTEO (forteoide) 560 mcg/2.24 mL pen injections on September 8, 2025, with completion scheduled for September 9, 2025. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order to be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. FORTEO is a prescription injectable medication commonly used in the treatment of osteoporosis...
- The Defense Logistics Agency awarded a delivery order valued at $12,499.08 to AmerisourceBergen Drug Corp for FORTEO (560 mcg/2.24 ml pen injections) on August 13, 2025, with an ultimate completion date of August 14, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's location in Conshohocken, Pennsylvania. FORTEO is an FDA-approved pharmaceutical treatment for osteoporosis and bone-related conditions, commonly utilized within military and...
- The Defense Logistics Agency awarded a $3,392.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of FORTEO (560 mcg/2.24 mL pen injections). This is a non-set-aside contract with an ultimate completion date of August 4, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. FORTEO is a prescription medication used primarily for treating osteoporosis in patients at high risk for fractures. This delivery order is...
- The Defense Logistics Agency awarded a $2,601.43 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of FORTEO (fortified with 560 mcg/2.24 mL pen injections). The contract, which became effective on August 7, 2025, with an ultimate completion date of August 8, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its Conshohocken facility....
- The Defense Logistics Agency awarded a $19,378.19 delivery order to AmerisourceBergen Drug Corp for FORTEO 560 MCG/2.24 ML pen injections on August 20, 2025, with completion scheduled for August 21, 2025. This competitive award, which utilized no set-aside designation, was issued under a firm fixed-price contract structure and represents a single delivery order for pharmaceutical supplies to be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. FORTEO is a bone-building...
- The Defense Logistics Agency awarded a $12,869.67 delivery order to AmerisourceBergen Drug Corp for FORTEO (560 mcg/2.24 mL pen injections), a brand-name pharmaceutical product used in osteoporosis treatment. The contract is a firm fixed-price delivery order with an ultimate completion date of May 19, 2025, and was competitively awarded without set-aside provisions. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $47,923.50 to AmerisourceBergen Drug Corp for the supply of FORTEO (560 mcg/2.24 mL pen injection), a pharmaceutical treatment for osteoporosis. The contract, awarded on April 21, 2025, with an ultimate completion date of April 22, 2025, was issued without a set-aside designation under a firm fixed price arrangement. Performance of this delivery order will take place at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $3,513.76 to AmerisourceBergen Drug Corp for FORTEO 560 MCG/2.24 ML pen injections on August 4, 2025, with completion scheduled for August 5, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The product will be delivered to AmerisourceBergen's corporate offices in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for FORTEO (teriparatide) 560 mcg/2.24 mL pen injections valued at $7,529.58. The award was issued on September 2, 2025, with an ultimate completion date of September 3, 2025, and represents a firm fixed price transaction with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate office as a primary...